Literature DB >> 20660775

Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex.

Mazdak Radjainia1, Jae-Kyung Hyun, Clinton E Leysath, Stephen H Leppla, Alok K Mitra.   

Abstract

The tripartite protein exotoxin secreted by Bacillus anthracis, a major contributor to its virulence and anthrax pathogenesis, consists of binary complexes of the protective antigen (PA) heptamer (PA63h), produced by proteolytic cleavage of PA, together with either lethal factor or edema factor. The mouse monoclonal anti-PA antibody 1G3 was previously shown to be a potent antidote that shares F(C) domain dependency with the human monoclonal antibody MDX-1303 currently under clinical development. Here we demonstrate that 1G3 instigates severe perturbation of the PA63h structure and creates a PA supercomplex as visualized by electron microscopy. This phenotype, produced by the unconventional mode of antibody action, highlights the feasibility for optimization of vaccines based on analogous structural modification of PA63h as an additional strategy for future remedies against anthrax.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660775      PMCID: PMC2922573          DOI: 10.1073/pnas.1006473107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Crystal structure of the anthrax toxin protective antigen.

Authors:  C Petosa; R J Collier; K R Klimpel; S H Leppla; R C Liddington
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

2.  Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin.

Authors:  S F Little; S H Leppla; E Cora
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

3.  Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.

Authors:  Fabien Brossier; Martine Lévy; Annie Landier; Pierre Lafaye; Michèle Mock
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies.

Authors:  Stephen F Little; Jeanne M Novak; John R Lowe; Stephen H Leppla; Yogendra Singh; Kurt R Klimpel; Burton C Lidgerding; Arthur M Friedlander
Journal:  Microbiology (Reading)       Date:  1996-03       Impact factor: 2.777

5.  Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study.

Authors:  Gang Ren; Joel Quispe; Stephen H Leppla; Alok K Mitra
Journal:  Structure       Date:  2004-11       Impact factor: 5.006

6.  Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.

Authors:  S F Little; B E Ivins; P F Fellows; A M Friedlander
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Crystal structure of a complex between anthrax toxin and its host cell receptor.

Authors:  Eugenio Santelli; Laurie A Bankston; Stephen H Leppla; Robert C Liddington
Journal:  Nature       Date:  2004-07-04       Impact factor: 49.962

8.  Three-dimensional reconstruction from a single-exposure, random conical tilt series applied to the 50S ribosomal subunit of Escherichia coli.

Authors:  M Radermacher; T Wagenknecht; A Verschoor; J Frank
Journal:  J Microsc       Date:  1987-05       Impact factor: 1.758

9.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis.

Authors:  Douglas S Reed; Jennifer Smoll; Paul Gibbs; Stephen F Little
Journal:  Cytometry       Date:  2002-09-01
View more
  12 in total

1.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

Review 2.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

3.  Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies.

Authors:  Siu-Kei Chow; Cameron Smith; Thomas MacCarthy; Mary Ann Pohl; Aviv Bergman; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

4.  The sub-nanomolar binding of DNA-RNA hybrids by the single-chain Fv fragment of antibody S9.6.

Authors:  Damilola D Phillips; David N Garboczi; Kavita Singh; Zonglin Hu; Stephen H Leppla; Clinton E Leysath
Journal:  J Mol Recognit       Date:  2013-08       Impact factor: 2.137

Review 5.  Antibodies against anthrax: mechanisms of action and clinical applications.

Authors:  Jeffrey W Froude; Philippe Thullier; Thibaut Pelat
Journal:  Toxins (Basel)       Date:  2011-11-16       Impact factor: 4.546

Review 6.  Monoclonal antibody therapies against anthrax.

Authors:  Zhaochun Chen; Mahtab Moayeri; Robert Purcell
Journal:  Toxins (Basel)       Date:  2011-08-15       Impact factor: 4.546

7.  An important role of α-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus.

Authors:  Sung-Wook Hong; Eun-Byul Choi; Taek-Ki Min; Ji-Hyun Kim; Min-Hye Kim; Seong Gyu Jeon; Byung-Jae Lee; Yong Song Gho; Young-Koo Jee; Bok-Yang Pyun; Yoon-Keun Kim
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

Review 8.  Channel-forming bacterial toxins in biosensing and macromolecule delivery.

Authors:  Philip A Gurnev; Ekaterina M Nestorovich
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

9.  Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized.

Authors:  Kejing Song; R Ranney Mize; Luis Marrero; Miriam Corti; Jason M Kirk; Seth H Pincus
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a.

Authors:  D N Shcherbinin; I B Esmagambetov; A N Noskov; Yu O Selyaninov; I L Tutykhina; M M Shmarov; D Yu Logunov; B S Naroditskiy; A L Gintsburg
Journal:  Acta Naturae       Date:  2014-01       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.